Scisparc (SPRC) Stock Price

Scisparc Price

NASDAQ·CLOSED
1.40
​
Market closed

Revenue at Scisparc has contracted by 4.3% per year over the past 15 years to 856,000.00 USD. Scisparc's net margin stands at -1,422.8%, down from -542.7% several years earlier.

Scisparc stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Scisparc business model & stock analysis

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Frequently asked questions about Scisparc

Converted at the current exchange rate, the Scisparc share trades at 1.25 EUR (1.40 USD).

The Scisparc share (SPRC) is listed on 1 stock exchanges, including: NASDAQ (SPRC).

The revenue cannot currently be calculated for Scisparc.

The profit cannot currently be calculated for Scisparc.

The P/E ratio cannot be calculated for Scisparc at the moment.

The P/S cannot be calculated for Scisparc currently.

The Eulerpool Quality Score for Scisparc is 2/10.

The ISIN of Scisparc is IL0010951403. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Scisparc is SPRC. The ticker symbol is used to trade Scisparc shares on the stock exchange.

Fair ValueTerminal
1.22 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
285,333.33 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website scisparc.com
Country
Israel
Currency
USD
Initial public offering
Dec 22, 2021
ISIN
IL0010951403
Cusip
M82618113
Market capitalization
43,120.00 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
0.48
P/B Ratio
0.01
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-264.47 %
Last updated Oct 20, 2026, 12:25 PM

Scisparc Peer Group

Scisparc Ticker

NASDAQ · SPRC

Scisparc FIGI

SPRC:US · BBG012BTGSV5SPRC:UA · BBG012BTGSW4SPRC:UC · BBG012BTGSX3SPRC:UN · BBG012BTGSZ1SPRC:UP · BBG012BTGT07SPRC:UB · BBG012BTGT25SPRC:UM · BBG012BTGT43SPRC:UX · BBG012BTGT52SPRC:UR · BBG012BTGT61SPRC:PQ · BBG012BTGT89SPRC:UD · BBG012BTGTB5SPRC:UF · BBG012BTGTF1

All fundamentals and in-depth analysis of Scisparc

Our stock analysis for Scisparc stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Scisparc. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.